HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fengtian Wu Selected Research

Fengtian Wu Research Topics

Disease

3Inflammation (Inflammations)
07/2022 - 01/2019
3Infections
11/2021 - 01/2021
3Neoplasms (Cancer)
01/2021 - 01/2020
2Acute Liver Failure (Fulminant Hepatic Failure)
07/2022 - 01/2020
2Liver Neoplasms (Liver Cancer)
01/2021 - 01/2020
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 01/2021
1Dehydration (Water Stress)
01/2023
1COVID-19
11/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Acute-On-Chronic Liver Failure
11/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Non-alcoholic Fatty Liver Disease
01/2021
1Autoimmune Hepatitis
01/2021
1Disease Progression
01/2021
1Liver Diseases (Liver Disease)
01/2021
1Primary Immunodeficiency Diseases
05/2020
1Smooth Muscle Tumor
05/2020
1Chronic Hepatitis B
01/2019
1Fibrosis (Cirrhosis)
01/2019

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2020
2GalactosamineIBA
07/2022 - 01/2020
1Benzyl Alcohol (Benzenemethanol)FDA Link
01/2023
1AnionsIBA
01/2023
1Benzyl AlcoholsIBA
01/2023
1CationsIBA
01/2023
1Sulfides (Thioethers)IBA
01/2023
1dibenzyl etherIBA
01/2023
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2022
1Immunoglobulin G (IgG)IBA
11/2022
1Bile Acids and Salts (Bile Acids)IBA
01/2022
1CytokinesIBA
11/2021
1Urokinase Plasminogen Activator ReceptorsIBA
11/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2021
1VaccinesIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1EnzymesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
12/2020
1Circulating Tumor DNAIBA
12/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1LipopolysaccharidesIBA
01/2020
1LigandsIBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Monoclonal AntibodiesIBA
01/2020
1Dinoprostone (PGE2)FDA Link
01/2019

Therapy/Procedure

3Therapeutics
11/2022 - 01/2020
2Transplantation
01/2021 - 05/2020
1Liver Transplantation
01/2021
1Precision Medicine
12/2020
1Immunotherapy
01/2020